Abstract
This document describes the contribution of clinical criteria to the interpretation of genetic variants using heritable Mendelian cardiomyopathies as an example. The aim is to assist cardiologists in defining the clinical contribution to a genetic diagnosis and the interpretation of molecular genetic reports. The identification of a genetic variant of unknown or uncertain significance is a limitation of genetic testing, but current guidelines for the interpretation of genetic variants include essential contributions from clinical family screening that can establish a de novo assignment of the variant or its segregation with the phenotype in the family. A partnership between clinicians and patients helps to solve major uncertainties and provides reliable and clinically actionable information.
Original language | English |
---|---|
Pages (from-to) | 1901-1916 |
Number of pages | 16 |
Journal | European Heart journal |
Volume | 43 |
Issue number | 20 |
DOIs | |
Publication status | Published - 21 May 2022 |
Keywords
- Cardiomyopathies
- Genetic variant
- Interpretation
- Pathogenicity
- Variants of uncertain significance (VUS)